β-defensins and LL-37 in bronchoalveolar lavage fluid of patients with cystic fibrosis

Journal of Cystic Fibrosis

Volumn 3, Issue 1, 2004, Pages 45-50

  Chen, Christiane I U ^a   Schaller Bals, Susanne ^b   Paul, Karl P ^a   Wahn, Ulrich ^a   Bals, Robert ^c  

^a HUMBOLDT UNIVERSITY   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c UNIVERSITY HOSPITAL MARBURG   (Germany)

Author keywords

Antimicrobial peptides; Bronchoalveolar lavage fluid; Cystic fibrosis; Innate immunity

Indexed keywords

BETA DEFENSIN 1; BETA DEFENSIN 2; CATHELICIDIN;

ADOLESCENT; ADULT; ARTICLE; BRONCHITIS; CHILD; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; CYSTIC FIBROSIS; DISEASE SEVERITY; FORCED EXPIRATORY VOLUME; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; LEUKOCYTE COUNT; LUNG DISEASE; LUNG FUNCTION; LUNG LAVAGE; MEASUREMENT; PROSPECTIVE STUDY; RESPIRATORY SYSTEM;

ADOLESCENT; ADULT; ANTIMICROBIAL CATIONIC PEPTIDES; BETA-DEFENSINS; BIOLOGICAL MARKERS; BRONCHOALVEOLAR LAVAGE FLUID; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; FEMALE; HUMANS; MALE; PROBABILITY; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC;

EID: 1642405248     PISSN: 15691993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcf.2003.12.008     Document Type: Article

References (35)

1. Davis P.B. Drumm M. Konstan M.W. Cystic fibrosis Am J Respir Crit Care Med 154 1996 1229-1256
2. Armstrong D.S. Grimwood K. Carzino R. Carlin J.B. Olinsky A. Phelan P.D. Lower respiratory infection and inflammation in infants with newly diagnosed cystic fibrosis BMJ 310 1995 1571-1572
3. Jia H.P. Schutte B.C. Schudy A. Linzmeier R. Guthmiller J.M. Johnson G.K. et al. Discovery of new human beta-defensins using a genomics-based approach Gene 263 2001 211-218
4. Garcia J.R. Krause A. Schulz S. Rodriguez-Jimenez F.J. Kluver E. Adermann K. et al. Human beta-defensin 4: a novel inducible peptide with a specific salt-sensitive spectrum of antimicrobial activity FASEB J 15 2001 1819-1821
5. Garcia J.R. Jaumann F. Schulz S. Krause A. Rodriguez-Jimenez J. Forssmann U. et al. Identification of a novel, multifunctional beta-defensin (human beta-defensin 3) with specific antimicrobial activity. Its interaction with plasma membranes of Xenopus oocytes and the induction of macrophage chemoattraction Cell Tissue Res 306 2001 257-264
6. Harder J. Bartels J. Christophers E. Schroder J.M. Isolation and characterization of human beta -defensin-3, a novel human inducible peptide antibiotic J Biol Chem 276 2001 5707-5713
7. Goldman M.J. Anderson G.M. Stolzenberg E.D. Kari U.P. Zasloff M. Wilson J.M. Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis Cell 88 1997 553-560
8. McCray P. Jr Bentley L. Human airway epithelia express a beta-defensin Am J Respir Cell Mol Biol 16 1997 343-349
9. Bals R. Wang X. Wu Z. Freeman Z. Banfa V. Zasloff M. et al. Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung J Clin Invest 102 1998 874-880
10. Harder J. Bartels J. Christophers E. Schroeder J.-M. A peptide antibiotic from human skin Nature 387 1997 861
11. Bals R. Wang X. Zasloff M. Wilson J.M. The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface Proc Natl Acad Sci USA 95 1998 9541-9546
12. Agerberth B. Grunewald J. Castanos-Velez E. Olsson B. Jornvall H. Wigzell H. et al. Antibacterial components in bronchoalveolar lavage fluid from healthy individuals and sarcoidosis patients Am J Respir Crit Care Med 160 1999 283-290
13. Gudmundsson G.H. Agerberth B. Odeberg J. Bergman T. Olsson B. Salcedo R. The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes Eur J Biochem 238 1996 325-332
14. Bals R. Wilson J.M. Cathelicidins-a family of multifunctional antimicrobial peptides Cell Mol Life Sci 60 2003 711-720
15. Ganz T. Lehrer R.I. Defensins Curr Opin Immunol 6 1994 584-589
16. Yang D. Chertov O. Bykovskaia S. Chen Q. Buffo M. Shogan J. et al. beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6 Science 286 1999 525-528
17. Yang D. Chen Q. Chertov O. Oppenheim J.J. Human neutrophil defensins selectively chemoattract naive T and immature dendritic cells J Leukocyte Biol 68 2000 9-14
18. Koczulla R. von Degenfeld G. Kupatt C. Krotz F. Zahler S. Gloe T. et al. An angiogenic role for the human peptide antibiotic LL-37/hCAP-18 J Clin Invest 111 2003 1665-1672
19. Smith J. Travis S. Greenberg E. Welsh M. Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid Cell 85 1996 229-236
20. Bals R. Weiner D.J. Meegalla R.L. Accurso F. Wilson J.M. Salt-independent abnormality of antimicrobial activity in cystic fibrosis airway surface fluid Am J Respir Cell Mol Biol 25 2001 21-25
21. Soong L. Ganz T. Ellison A. Caughey G. Purification and characterization of defensins from cystic fibrosis sputum Inflamm Res 46 1997 98-102
22. Matsushita I. Hasegawa K. Nakata K. Yasuda K. Tokunaga K. Keicho N. Genetic variants of human beta-defensin-1 and chronic obstructive pulmonary disease Biochem Biophys Res Commun 291 2002 17-22
23. Ratjen F. Rietschel E. Griese M. Ballmann M. Kleinau I. Doring G. et al. Fractional analysis of bronchoalveolar lavage fluid cytology in cystic fibrosis patients with normal lung function. Bronchoalveolar lavage for the evaluation of anti-inflammatory treatment (BEAT) study group Eur Respir J 15 2000 141-145
24. Gaultier C. Fletcher M.E. Beardsmore C. England S. Motoyama E. Respiratory function measurements in infants: measurement conditions. Working group of the European respiratory society and the American thoracic society Eur Respir J 8 1995 1057-1066
25. Bals R. Weiner D.J. Meegalla R.L. Wilson J.M. Transfer of a cathelicidin peptide antibiotic gene restores bacterial killing in a cystic fibrosis xenograft model J Clin Invest 103 1998 1113-1117
26. Schaller-Bals S. Schulze A. Bals R. Increased levels of antimicrobial peptides in tracheal aspirates of newborn infants during infection Am J Respir Crit Care Med 165 2002 992-995
27. Ashitani J. Mukae H. Hiratsuka T. Nakazato M. Kumamoto K. Matsukura S. Plasma and BAL fluid concentrations of antimicrobial peptides in patients with mycobacterium avium-intracellulare infection Chest 119 2001 1131-1137
28. Ashitani J. Mukae H. Hiratsuka T. Nakazato M. Kumamoto K. Matsukura S. Elevated levels of alpha-defensins in plasma and BAL fluid of patients with active pulmonary tuberculosis Chest 121 2002 519-526
29. Bals R. Weiner D. Wilson J. The innate immune system in cystic fibrosis lung disease J Clin Invest 103 1999 303-307
30. Agerberth B. Gunne H. Odeberg J. Kogner P. Boman H.G. Gudmundsson G.H. FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bane marrow and testis Proc Natl Acad Sci USA 92 1995 195-199
31. Yang D. Chen Q. Schmidt A.P. Anderson G.M. Wang J.M. Wooters J. et al. LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T-cells J Exp Med 192 2000 1069-1074
32. Barnes P.J. Endogenous inhibitory mechanisms in asthma Am J Respir Crit Care Med 161 2000 S176-S181
33. Islam D. Bandholtz L. Nilsson J. Wigzell H. Christensson B. Agerberth B. et al. Downregulation of bactericidal peptides in enteric infections: a novel immune escape mechanism with bacterial DNA as a potential regulator Nat Med 7 2001 180-185
34. Dunsmore S.E. Saarialho-Kere U.K. Roby J.D. Wilson C.L. Matrisian L.M. Welgus H.G. et al. Matrilysin expression and function in airway epithelium J Clin Invest 102 1998 1321-1331
35. Wilson C.L. Ouellette A.J. Satchell D.P. Ayabe T. Lopez-Boado Y.S. Stratman J.L. et al. Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense Science 286 1999 113-117